VINCVincerx Pharma, Inc.

Nasdaq vincerx.com


$ 0.76 $ 0.02 (2.83 %)    

Monday, 26-Aug-2024 15:51:57 EDT
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 0.771
$ 0.77
$ 0.77 x 100
-- x --
$ 0.75 - $ 0.77
$ 0.51 - $ 9.37
275,595
na
22.88M
$ 0.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-28-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-22-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 09-23-2020 06-30-2020 10-K
18 05-06-2020 03-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vincerx-pharma-q1-eps-058-misses-029-estimate

Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0....

 why-vincerx-pharma-vinc-stock-is-falling

Vincerx Pharma shares are trading lower by 9.7% to $0.81 during Friday's session. The company priced an underwritten public...

 vincerx-pharma-sets-pricing-for-new-public-offering-of-shares-and-warrants

Vincerx Pharma, Inc. (NASDAQ:VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of it...

 vincerx-pharma-announces-proposed-underwritten-public-offering-of-common-stock-and-warrants-no-size-or-amount-disclosed

Vincerx Pharma, Inc. (NASDAQ:VINC) today announced a proposed underwritten public offering of shares of its common stock and ac...

 crude-oil-down-over-1-cognyte-software-shares-plummet

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 dow-dips-150-points-laser-photonics-shares-spike-higher

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded...

 why-is-small-cap-cancer-focused-vincerx-pharma-stock-plummeting-on-tuesday

Preliminary Phase 1 data for VIP236 and updates on pipeline progress presented by Vincerx Pharma at AACR Annual Meeting 2024. R...

 dow-gains-over-50-points-neogen-posts-downbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market openi...

 cantor-fitzgerald-reiterates-overweight-on-vincerx-pharma

Cantor Fitzgerald analyst Li Watsek reiterates Vincerx Pharma (NASDAQ:VINC) with a Overweight.

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION